Vicarious Surgical (NYSE:RBOT) announced third-quarter results that included an update on planned clinical trials for its ...

I cover the intersection of sports and money. Zimmerman and Howard have the odds stacked against them with regard to the complaints that they filed, but does that matter? The filing of lawsuits ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Eye-care group Alcon cut its 2024 forecasts and missed market expectations for third-quarter sales on Tuesday evening, as a soft U.S. market hit its surgical business. Alcon, whose biggest market is ...

In a report released on November 8, Ryan Zimmerman from BTIG maintained a Buy rating on RxSight (RXST – Research Report), with a price target of $58.00. The company’s shares closed last Friday at ...

Good morning, ladies and gentlemen, and welcome to the Humacyte Third Quarter 2024 Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and ...

says Ryan Mackew was last seen leaving his home on Sept. 18. He is believed to be in or around Minneapolis, about 40 miles south of Zimmerman. Mackew is 5 feet 7 inches tall and weighs about 140 ...

It’s still early November, so the Hot Stove is far from heating up. But with this past week getting us further removed from ...

Analyst Ryan Zimmerman from BTIG reiterated a Buy rating on Glaukos (GKOS – Research Report) and increased the price target to $140.00 ...

Ryan Zimmerman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth ...

Just like we expected D3 to be the most progressive, District 4 (West/Sellwood) ended up most moderate. It also has one of ...

In the last year, museums, book festivals, arts journals and other organizations have experienced bitter discord over what ...